SPDR Biotech ETF News
Biotechs Weakened by The Stock Market Rout
Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.
Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?
Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.
Biotech Stocks Could Rally
Valuations for biotech stocks have slumped, but could rebound.
Insiders Are Buying Biotech Stocks Again
Things may be looking up for biotech stocks, says Real Money's Bret Jensen.
Why Stocks Do Better After Getting Kicked Out of the Dow
Mark Hulbert explains why the most popular stocks often prove to be disappointing performers.
Fed Inflation Gauge Eases Again In May, But Inflation Pressures Clip Consumer Spending
While overall inflation pressures are easing modestly, the impact of the fastest inflation in four decades is taking its toll on spending, BEA data indicated Thursday.
Pfizer Seeks Formal FDA Approval For Covid Oral Treatment Paxlovid
“As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.
Walgreens Stock Slides After Q3 Profit Beat, $683 Million Florida Opioid Charge
"WBA delivered strong execution across operating segments and against very robust growth last year," said CEO Rosalind Brewer.
Micron Earnings Preview: Will Critical Support Hold?
Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?